Dr. Prasada Raju
Managing Director and CEO
Dr. V. Prasada Raju is the Managing Director and Chief Executive Officer of the Company. He was appointed on 27th October 2020 as the Whole-Time Director and Chief Executive Officer of the Company and consequently appointed as Managing Director and Chief Executive Officer with effect from 10th March 2021. He is responsible for the overall business of the Company and is reporting to the Board of Directors of the Company.
In addition to having a PhD in chemistry and PG Dip in patents law, he is also an alumina of the IIMc under Sr Management programme and IIT, Chicago, USA, where he was trained in material sciences.
He has 27+ years of techno commercial experience in the pharmaceutical space across the value chain, Dr Prasada Raju served in various leadership roles at Granules India Limited and Dr. Reddy’s Laboratories.
He served as an Executive Director in Granules India Ltd. Responsible for driving Growth strategy, Product portfolio, Scientific affairs, Regulatory affairs, Intellectual property and New Business initiatives. Led and built R&D and Green field projects. Also served on the Boards of Granules Omnichem Pvt ltd (Vizag, India), Granules Pharmaceuticals Inc., (DC, USA) and USpharma ltd (FL, USA).
Granules was his second professional assignment between 2012 and 2019
Prior to this, he served as a Director, Project Management, Integrated Product development Organisation of Dr. Reddy’s Laboratories. It includes over 17+ years of techno commercial experience, providing technical, strategic and operational leadership in uniquely challenging positions across various disciplines of pharma (1994-2012).
Mr. Bhaskar Iyer
Bhaskar Iyer is an Independent Director of the Company with effect from 27th October 2020 for a period of five years.. Mr. Bhaskar Iyer is a strategic business leader with over four decades of experience in the pharmaceutical and healthcare industry spanning country management, global leadership and Board Directorship roles.
Since 2007 he has been managing teams comprising of Managing Directors and Function Heads and in the last role at Abbott India, the leading healthcare company in India, he managed a team of 12000 employees and a turnover of a billion US dollars.. During this period, he was a Corporate Officer with Abbott for the India region, leading sales, manufacturing and R&D operations. Mr. Iyer has also held global leadership positions for Wockhardt in India, AstraZeneca in Asia-Pacific based in Singapore and country management positions in AstraZeneca, Nicholas Piramal India Limited, ICI Pharmaceuticals and senior roles in Glaxo India Limited. Mr. Iyer is also an Operating Advisor at a healthcare-focussed Private Equity firm, Quadria Capital. Bhaskar Iyer serves on the Board of Directors of Bharat Serums and Vaccines Limited, RPG Life Sciences Limited and Pharmarack Technologies Private Limited as Independent Director
Mr. Abhijit Mukherjee
Abhijit Mukherjee is an Independent Director of the Company with effect from 27th October, 2020 for a period of five years.. A chemical engineer from IIT-Kharagpur, Mr. Mukherjee superannuated from Dr. Reddy’s in March 2018 after playing varied senior roles there for 15 years; the last stint at Dr. Reddy’s was as COO from 2014 to 2018.
Mr. Mukherjee had worked with Hindustan Lever for 13 years and with Atul Limited for nine years. Apart from serving on the board of Bharat Serums and Vaccines Limited, Mr. Mukherjee is on the board of ICE in Milan, Italy and Slayback, a company incorporated in New Jersey, USA.
Mr. Anil Kumar Chanana
Mr. Anil Chanana is an Independent Director on the Board of our Company with effect from 15th December 2021. He holds a bachelor’s degree in commerce (Honours course) from the University of Delhi and has completed the financial management program at the Stanford Graduate School of Business. He is an associate member of the Institute of Chartered Accountants of India which he did in 1980.
He has 40 years of experience covering global IT and analytics. He has previously served as the Chief Financial Officer of HCL Technologies Limited and worked closely with the Board and its committees in formulating and executing strategic priorities. He has played leadership roles in areas like Finance, M&A, Procurement, Risk Management and Corporate Restructuring.
Currently, Mr. Anil Chanana is acting as business consultant in strategy and finance. He is serving on the boards of companies in snack food, sports and athleisure footwear, and health benefits administration as independent director and chairperson of the audit committee.
Mr. Ashok Kumar Jain
Mr. Ashok Jain joined the Board of RA Chem Pharma Limited on 27th October, 2020 as a Non-Executive Director. Mr. Ashok Jain has a vast experience of more than 40 years. He is the Executive Director of Micro Labs Ltd. In his current role, he is responsible for Business of India, Americas, Mexico, Australia and New initiatives brings with him 40 years of Pharma Industry experience.
Prior to Micro labs Ltd, Ashok was instrumental in managing Ranbaxy’s formulation business worth USD 325 M as Vice President Country and regional head. Before Ranbaxy he was associated with Unichem Laboratories as Chief Executive (Pharma), managing the India formulations business.
Ashok has done his MBA from IIM Ahmadabad and completed his post-graduation in Food Technology with minor in Biochemistry, Ashok also did Global Advance Management from ISB- Kellogg.
Ashok has been actively associated with Industry forums such as IPA (Indian Pharmaceutical Alliance) and associated with premier management institutes (IPHMR, NMIMS).
Ms. Shweta Jalan
Ms. Shweta Jalan is a Non-Executive Director of the Company with effect from 27th October, 2020. Shweta Jalan is the Managing Director of Advent India PE Advisors Private Limited (Advent), and as Managing Director, Shweta Jalan has been associated with Advent since 2009. Before joining Advent, Ms. Jalan worked with ICICI Venture, the largest private equity firm in India.
Ms. Jalan had spent a year with the corporate finance division of Ernst & Young. Ms. Jalan is also a Director on Board of Directors of various Companies some of them being Bharat Serums and Vaccines Limited, Crompton Greaves Consumers Limited, Dixcy Textiles Private Limited, Manjushree Technopack Limited, ASK Investment Managers Private Limited, Manjushree Technopack Limited and QuEST Global Services Pte Ltd.
Ms. Jalan has experience in sourcing and negotiating transactions and has worked across a wide range of sectors including industrial, media, business services to IT/BPO. She also offers her counsel on managing investments and planning successful exits, viz. sale to strategic buyers and the listing of companies.
Mr. Pankaj Patwari
Mr. Pankaj Patwari is a Non-Executive Director of the Company with effect from 27th October, 2020. Mr. Patwari is a Chartered Accountant by training and he holds an MBA from the Indian Institute of Management (Lucknow).
As Director - Advent India PE Advisors Private Limited, Mr. Pankaj Patwari has been managing Advent's investments in Crompton Greaves Consumer Electricals Limited from 2014 apart from Manjushree Technopack Limited, QuEST Global and Bharat Serums and Vaccines Ltd. He also serves of the Board of Directors of various many other Companies notably Bharat Serums and Vaccines Limited, Manjushree Technopack Limited and Gokaldas Intimatewear Private Limited. Previously, Mr. Patwari had spent six years with Bain Capital working on several transactions in the pharmaceutical and industrial sectors. Prior to his stint at Bain, Mr. Patwari spent four years with McKinsey & Co., focusing primarily on financial services.